Potential Cancer Treatment Derived From Ancient Chinese Folk Remedy

A group of promising cancer-fighting compounds derived from a substance used in ancient Chinese medicine will be developed for potential use in humans, the University of Washington announced today. The UW TechTransfer Office has signed a licensing agreement with Chongqing Holley Holdings, a Chinese company, and Holley Pharmaceuticals, its U.S. subsidiary. The compounds, all developed through the research of UW scientists Henry Lai and Narendra Singh of the Department of Bioengineering and Tomikazu Sasaki of the Department of Chemistry, make use of a substance known as artemisinin, found in the wormwood plant and used throughout Asia since ancient times to treat malaria.

Back to news